The founder and chief executive officer of SQZ Biotech discussed the potential of their APC platform to treat a variety of tumors.
Armon Sharei, PhD
Advertisement
Chief executive officer and founder, SQZ Biotech
Articles by Armon Sharei, PhD
The founder and chief executive officer of SQZ Biotech discussed the development and advantages of their proprietary Cell Squeeze technology in creating cell therapies.
Advertisement
Latest Updated Articles
Advantages of Cell Squeeze Technology Over Electroporation and Viral TransfectionPublished: July 15th 2021 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
2
Crawford Strunk, MD, on the Importance of Palliative Care in Sickle Cell Disease
3
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
4
CGTLive®’s Weekly Rewind – December 5, 2025
5
